CD8A and diabetes mellitus: Most strikingly, the construct-expressing eTreg targeting the CD8+ T cells reduced the development of spontaneous autoimmune diabetes in NOD mice given only 2 doses at the pre-diabetic stage, in contrast to mock-transfected Tregs, which did not protect from diabetes when given with the same protocol in young mice (Figure 9).